Martin Akerman | CTO & Co-Founder
Envisagenics

Martin Akerman, CTO & Co-Founder, Envisagenics

Dr. Martin Akerman is the Co-founder and CTO of Envisagenics, who has created an artificial intelligence platform to identify druggable splicing errors from large amounts of RNA-seq data. Dr. Akerman did his postdoc with Dr. Adrian Krainer and Dr. Michael Zhang at Cold Spring Harbor Laboratory and received his PhD in Bioinformatics from Technion, Israel institute of Technology. His mission at Envisagenics is to advance the world’s ability to cure diseases by discovering new and more efficient drug targets through the analysis and integration of transcriptome data

Appearances:



BioData West- NASA Ames Satellite Conference & Workshops @ 16:10

VC and Investors Showcase

15:50- SpliceCore: Drug Target Discovery with Splicing AI
Martin Akerman, CTO, Cofounder, Envisagenics
16:00-  Autism Diagnostics Technologies
Andrew Stewart, CEO and Founder, Autism Diagnostics
16:10 - Mendel.AI
Karim Galil, CEO and Founder, Mendel.AI
16:20 – Elastic Genomics
Chris Probert, Founder, Elastic Genomics (in stealth mode)
16:30- Improve patient identification in cardiovascular by using machine learning – concrete case
Adrien Rousset, Innovation Manager, Amgen
16:40- Neuroscence Inc
Yasaman Soudagar, CEO and Founder, Neurescence Inc
16:50-  ProteinQure Inc
Mark Fingerhuth, CEO and Founder, ProteinQure Inc
 

back to speakers